Home / Inspections / 1030229

FDA Inspection 1030229 — Chartwell Pharmaceuticals West Caldwell LLC

Chartwell Pharmaceuticals West Caldwell LLC — FEI 3005376609

The FDA completed an inspection of Chartwell Pharmaceuticals West Caldwell LLC on September 18, 2017 in West Caldwell, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 18, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
West Caldwell, NJ (United States)

Facility

Other inspections at this facility

  • 973194 (VAI Wed May 25 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 847035 (NAI Fri Sep 06 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 740705 (VAI Wed Sep 07 2011 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources